Literature DB >> 16831468

Serotonin 1a receptor and associated G-protein activation in schizophrenia and bipolar disorder.

Laura Gray1, Elizabeth Scarr, Brian Dean.   

Abstract

Abnormalities in the serotonergic signalling system, including the serotonin 1a receptor, have been implicated in the pathogenesis of schizophrenia and bipolar 1 disorder. However, there is no consensus on whether the density of the serotonin 1a receptor and/or the activity of the G-proteins linking the receptor to the intracellular cascade are altered in these disease states. To address these issues, tissue obtained postmortem from four cortical regions was used to measure [3H] 8-hydroxy-2-(dipropylamino)tetralin hydrobromide (8-OH-DPAT) binding and 8-OH-DPAT-stimulated guanosine 5'-[gamma-thio]triphosphate (GTPgammaS) binding to determine if either parameter is altered in schizophrenia or bipolar I disorder. There was an effect of diagnosis on the level of [3H] 8-OH-DPAT binding that may indicate a global change in the density of serotonin 1a receptors, although this effect did not reach significance in any individual brain region. The activation of serotonin 1a receptors did not differ significantly with diagnoses. However, in the outer cortical layers, there appeared to be a dissociation between the number of receptors available and the extent of ligand-induced GTPgammaS binding, suggesting considerable receptor reserve. In addition, comparing gender independent of diagnoses, a decrease in the levels of serotonin 1a receptors was observed in the cortex of female subjects. These data indicates that there may be subtle changes in serotonin 1a receptors across the cortex in schizophrenia or bipolar I disorder and suggests a gender discordance in receptor levels.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16831468     DOI: 10.1016/j.psychres.2005.09.010

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  9 in total

Review 1.  5-HT(1A) receptor function in major depressive disorder.

Authors:  Jonathan Savitz; Irwin Lucki; Wayne C Drevets
Journal:  Prog Neurobiol       Date:  2009-02-07       Impact factor: 11.685

2.  Human Freud-2/CC2D1B: a novel repressor of postsynaptic serotonin-1A receptor expression.

Authors:  Mahmoud R Hadjighassem; Mark C Austin; Bernadeta Szewczyk; Mireille Daigle; Craig A Stockmeier; Paul R Albert
Journal:  Biol Psychiatry       Date:  2009-05-07       Impact factor: 13.382

3.  Reduced post-synaptic serotonin type 1A receptor binding in bipolar depression.

Authors:  Allison C Nugent; Earle E Bain; Paul J Carlson; Alexander Neumeister; Omer Bonne; Richard E Carson; William Eckelman; Peter Herscovitch; Carlos A Zarate; Dennis S Charney; Wayne C Drevets
Journal:  Eur Neuropsychopharmacol       Date:  2013-02-20       Impact factor: 4.600

4.  Altered G Protein Coupling in Olfactory Neuroepithelial Cells From Patients With Schizophrenia.

Authors:  Karin E Borgmann-Winter; Hoau-Yan Wang; Rabindranath Ray; Brooke R Willis; Paul J Moberg; Nancy E Rawson; Raquel E Gur; Bruce I Turetsky; Chang-Gyu Hahn
Journal:  Schizophr Bull       Date:  2015-09-15       Impact factor: 9.306

5.  Case-control association study for 10 genes in patients with schizophrenia: influence of 5HTR1A variation rs10042486 on schizophrenia and response to antipsychotics.

Authors:  Concetta Crisafulli; Alberto Chiesa; Changsu Han; Soo-Jung Lee; Moon Ho Park; Beatrice Balzarro; Costanza Andrisano; Ashwin A Patkar; Chi-Un Pae; Alessandro Serretti
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-11-27       Impact factor: 5.270

6.  Effects of selective 5-HT1A agonist tandospirone on the rate and rhythmicity of binocular rivalry.

Authors:  Masanori Nagamine; Aihide Yoshino; Masaki Miyazaki; Yoshitomo Takahashi; Soichiro Nomura
Journal:  Psychopharmacology (Berl)       Date:  2008-04-12       Impact factor: 4.530

7.  Mood stabilizer treatment increases serotonin type 1A receptor binding in bipolar depression.

Authors:  Allison C Nugent; Paul J Carlson; Earle E Bain; William Eckelman; Peter Herscovitch; Husseini Manji; Carlos A Zarate; Wayne C Drevets
Journal:  J Psychopharmacol       Date:  2013-08-07       Impact factor: 4.153

8.  Cholinergic connectivity: it's implications for psychiatric disorders.

Authors:  Elizabeth Scarr; Andrew S Gibbons; Jaclyn Neo; Madhara Udawela; Brian Dean
Journal:  Front Cell Neurosci       Date:  2013-05-03       Impact factor: 5.505

Review 9.  Towards in vivo imaging of functionally active 5-HT1A receptors in schizophrenia: concepts and challenges.

Authors:  Oriane Razakarivony; Adrian Newman-Tancredi; Luc Zimmer
Journal:  Transl Psychiatry       Date:  2021-01-07       Impact factor: 6.222

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.